COSMED - ROOT ENGLISH

Best wishes for Christmas Season from COSMED family! In this unusually difficult Holiday Season, we wish you a safe Christmas in a quiet and cozy corner with your family and friends! We all know that 2020 has certainly been a very challenging year for everyone, both privately and professionally and we can only hope that 2021 will be better. We appreciate your cooperation and we want to thank...

COSMED introduces BOD POD GS-X, the 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model. COSMED, world-wide leader manufacturer of Cardiopulmonary, Metabolic and Body Composition diagnostic equipment for clinical and human performance applications, announced today the release of BOD POD GS-X, a new...

COSMED wins the award "Best company on stage", the recognition delivered every year by Campus Bio-Medico University in Rome to those companies that have made possible a positive collaboration with the University for welcoming the largest number of trainees. "The idea is to give recognition to those who help us to complete our training course with an internship", explains Roberto...

Progetto Q-NRG INT-P Cofinanziato dall'Unione Europea - www.europa.eu Avviso Pubblico “Voucher Internazionalizzazione” di cui alla Det. n. G10195 del 26/07/2019 - POR FESR LAZIO 2014-2020 – CUP F14E20000090007 – Domanda prot. n. A0331-2019-31351 Progetto approvato con Determinazione n. G02590 del 06/03/2020 pubblicata sul BURL n. 23 del 10/03/2020 Titolo del progetto: “Q-NRG...

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max). Innovision’s products are a perfect match to...

More Articles …

CONTACT US

CONTACT US

SUPPORT

SUPPORT

FOLLOW US ON

FOLLOW US ON